NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John TrizzinoPresident and COO2025-03-0713,954$8.34
$116.38kSell
James Patrick KellyEVP CFO and Treasurer2025-03-075,904$8.34
$49.24kSell
Mark J. CaseyEVP Chief Legal Officer2025-03-011,214$8.33
$10.11kSell
John C. JacobsPresident and CEO2025-03-0138,451$8.33
$320.30kSell
John TrizzinoPresident and COO2025-03-0123,185$8.33
$193.13kSell
Elaine OharaEVP Chief Strategy Officer2025-03-0110,969$8.33
$91.37kSell
James Patrick KellyEVP CFO and Treasurer2025-03-0128,337$8.33
$236.05kSell
Elaine OharaEVP Chief Strategy Officer2025-03-015,375$8.33
$44.77kSell
John C. JacobsPresident and CEO2025-01-2338,873$9.55
$371.24kSell
James F. YoungDirector2024-12-315,400$8.00
$43.20kSell

1 of 3

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.68%15,674,378$103.61MInstitution
Blackrock Inc8.01%12,967,029$85.71MInstitution
Shah Capital Management6.87%11,131,846$73.58MInstitution
Cadila Pharmaceuticals Ltd5.87%9,500,000$62.80MInsider
State Street Corp4.35%7,039,158$46.53MInstitution
Sanofi4.25%6,880,481$45.48MInstitution
James B. 1. Tananbaum3.87%6,268,455$41.43MInsider
Sj Strategic Investments LLC2.47%4,001,500$26.45MInsider
Coatue Management LLC2.37%3,836,986$25.36MInstitution
Geode Capital Management LLC2.32%3,764,008$24.88MInstitution

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX60.78%17.16%Net Selling
MNKD35.95%64.05%Net SellingNet Selling
NTLA72.20%27.80%Net SellingNet Selling
ABCL41.78%44.65%Net Buying
OCS8.96%0.00%

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 60.78% institutional shareholders, 17.16% Novavax insiders, and 22.06% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.87% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $64.22M.

If you're new to stock investing, here's how to buy Novavax stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.